Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness Report.

Current oncology (Toronto, Ont.)·2026
Same author

Interferon-Inducible Gene Upregulation Correlates With Successful Viral Clearance in Patients With BK Polyomavirus-Associated Nephropathy.

Kidney international reports·2026
Same author

Corrigendum to "Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international study" [American Journal of Transplantation 25 (2025) 1631-1642].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

BMC genomic data·2026
Same author

Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Biopsy-confirmed Mycobacterium kansasii peritonitis with CT peritoneography in a young PD patient: a case report.

BMC nephrology·2026
Same journal

Histoplasmosis in kidney transplant recipients.

BMC nephrology·2026
Same journal

Severe metabolic acidosis with renal tubular acidosis features attributed to topical brinzolamide in a patient with stage 3 chronic kidney disease: a case report.

BMC nephrology·2026
Same journal

Spatial transcriptomic profiling reveals molecular signatures of endocapillary hypercellularity in IgA nephropathy.

BMC nephrology·2026
Same journal

Acetate ameliorates membranous nephropathy by modulating the immune response and podocyte function.

BMC nephrology·2026
Same journal

Consecutive PRES and diffuse alveolar hemorrhage in a patient with active lupus nephritis and antiphospholipid antibodies: a case report and systematic literature review.

BMC nephrology·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K

Transplant biopsy beyond light microscopy.

Benjamin Adam1, Michael Mengel2

  • 1Department of Laboratory Medicine and Pathology, University of Alberta, T6G 2S2, Edmonton, Canada. baadam@ualberta.ca.

BMC Nephrology
|August 8, 2015
PubMed
Summary
This summary is machine-generated.

Molecular pathology offers precise diagnoses for kidney transplant rejection, moving beyond traditional biopsy limitations. Future integration of molecular, clinical, and imaging data promises enhanced diagnostic accuracy.

More Related Videos

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

9.8K
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
09:17

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy

Published on: May 3, 2019

7.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

9.8K
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
09:17

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy

Published on: May 3, 2019

7.9K

Area of Science:

  • Transplantation pathology
  • Molecular diagnostics
  • Renal transplantation

Background:

  • Current renal transplant biopsy relies on descriptive classifications, insufficient for personalized medicine's demand for mechanism-based diagnoses.
  • Traditional pathology standards in transplantation do not fully meet the need for precise diagnostic, prognostic, and therapeutic targets.

Purpose of the Study:

  • To review the current state of molecular renal transplantation pathology.
  • To highlight the potential of molecular techniques in providing pathogenetic insights for improved diagnostics and therapeutics.
  • To discuss barriers and future directions for the clinical adoption of molecular testing in transplantation.

Main Methods:

  • Review of current research and progress in molecular renal transplantation pathology.
  • Discussion of novel molecular platforms for formalin-fixed paraffin-embedded tissues.
  • Analysis of the incorporation of molecular criteria into the Banff classification.

Main Results:

  • Significant research progress has been made, but routine clinical molecular testing adoption is limited.
  • Molecular platforms for FFPE tissues offer solutions to implementation barriers.
  • Transcripts linked to endothelial injury and NK cell activation correlate with antibody-mediated rejection.

Conclusions:

  • Molecular pathology is advancing, with recent Banff classification updates reflecting progress.
  • Prospective multicenter validation of molecular diagnostics for key entities is an unmet need.
  • An integrated diagnostic system combining molecular, morphological, serological, and clinical data will offer the highest diagnostic precision.